Mereo BioPharma Group Plc (MREO)
0.5322
0.00 (0.00%)
USD |
NASDAQ |
Jan 22, 16:00
0.545
+0.01
(+2.41%)
After-Hours: 07:36
Mereo BioPharma Group Research and Development Expense (TTM): 22.37M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 6.352M |
| NuCana Plc | 15.52M |
| Autolus Therapeutics Plc | 112.76M |
| Bicycle Therapeutics Plc | 279.03M |
| Ultragenyx Pharmaceutical, Inc. | 699.19M |